Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 16553529)

1.

An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder.

Berard R, Fong R, Carpenter DJ, Thomason C, Wilkinson C.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):59-75.

PMID:
16553529
2.

Escitalopram therapy for major depression and anxiety disorders.

Baldwin DS, Reines EH, Guiton C, Weiller E.

Ann Pharmacother. 2007 Oct;41(10):1583-92. Epub 2007 Sep 11. Review.

PMID:
17848424
3.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
4.

Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine.

Apter A, Lipschitz A, Fong R, Carpenter DJ, Krulewicz S, Davies JT, Wilkinson C, Perera P, Metz A.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):77-90. Review.

PMID:
16553530
5.

A review of pharmacotherapy of major depression in children and adolescents.

Ambrosini PJ.

Psychiatr Serv. 2000 May;51(5):627-33. Review.

PMID:
10783181
6.

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials.

Faries DE, Heiligenstein JH, Tollefson GD, Potter WZ.

J Clin Psychopharmacol. 2001 Dec;21(6):561-8. Review.

PMID:
11763002
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk